Saturday, September 4, 2010

Hooray, Flip Flop by the FDA!

According to The New York Times, the FDA has reconsidered its decision to remove midodrine (ProAmatine) from the market due to the many complaints received by POTS patients like us that find it necessary for everyday living. The FDA has backtracked from it's original decision, and will now allow midodrine to continue to be sold.(YAY!) Finally, the chronically ill are listened to by a government agency…that must be some kind of record! Good news all around.

Please see the link below for the full article from The New York Times.

F.D.A. Backtracks and Returns Drug to Market


Rusty Hoe said...

Yay. It's worthy of celebration. :)

Vegan Danielle Davis said...

hey sweetie! thanks for this post! i hope you don't mind, i shared the love on my blog, and of course, linked to you as well. have a great day!!! :)


To make you smile...


Sweet boy

Chloe Bear

Chloe Bear
Chloe as a baby!